🇪🇺 Sie wollen mehr Transparenz in der EU? Entdecken Sie unsere EU-Recherchen!

Zulassungsantrag und Beurteilungsbericht für den Impfstoff mRNA-1273 von Moderna

den Zulassungsantrag und den Beurteilungsbericht für den Impfstoff mRNA-1273 von Moderna

Anfrage erfolgreich

  • Datum
    6. Januar 2021
  • Frist
    27. Januar 2021
  • 4 Follower

    Erhalten Sie Neuigkeiten per Email.

<< Anfragesteller/in >>
Antrag nach EU-Verordnungen 1049/2001 sowie 1367/2006 Sehr geehrteAntragsteller/in auf Basis der Verordnungen 104…
An Europäische Arzneimittel-Agentur Details
Von
<< Anfragesteller/in >>
Betreff
Zulassungsantrag und Beurteilungsbericht für den Impfstoff mRNA-1273 von Moderna [#208044]
Datum
6. Januar 2021 21:34
An
Europäische Arzneimittel-Agentur
Status
Warte auf Antwort — E-Mail wurde erfolgreich versendet.
Antrag nach EU-Verordnungen 1049/2001 sowie 1367/2006 Sehr geehrteAntragsteller/in auf Basis der Verordnungen 1049/2001 sowie 1367/2006 bitte ich Sie um Übersendung von Dokumenten, die folgende Informationen enthalten:
den Zulassungsantrag und den Beurteilungsbericht für den Impfstoff mRNA-1273 von Moderna
Ich weise ausdrücklich darauf hin, dass ich eine Antwort per E-Mail an diese Adresse und nicht über ein Webportal wünsche. Ich möchte Sie um eine Empfangsbestätigung bitten und danke Ihnen für Ihre Mühe! Mit freundlichen Grüßen Antragsteller/in Antragsteller/in Anfragenr: 208044 Antwort an: <<E-Mail-Adresse>> Laden Sie große Dateien zu dieser Anfrage hier hoch: https://fragdenstaat.de/a/208044/ Postanschrift Antragsteller/in Antragsteller/in << Adresse entfernt >>
Mit freundlichen Grüßen << Anfragesteller/in >>
Europäische Arzneimittel-Agentur
Dear Sir/Madam **ASK-77120 ( https://servicedesk.ema.europa.eu/jira/… ) - Zulassungsantrag und Beurteilungsberich…
Von
Europäische Arzneimittel-Agentur
Betreff
[EMA Service Desk] AskEMA ASK-77120 - Zulassungsantrag und Beurteilungsbericht für den Impfstoff mRNA-1273 von Moderna [#208044]
Datum
7. Januar 2021 13:06
Status
Anfrage abgeschlossen
e6c72e36-2ad7-4a3d-851a-c8e6daa55ba7__issueType.png
737 Bytes


Dear Sir/Madam **ASK-77120 ( https://servicedesk.ema.europa.eu/jira/… ) - Zulassungsantrag und Beurteilungsbericht für den Impfstoff mRNA-1273 von Moderna [#208044] received on 7/Jan/21** Thank you for submitting your request. This is an automated response to confirm that we have received your request; please do not respond directly to this message as this email address is not monitored. A member of Agency staff will now review your request. We will send an acknowledgement of receipt to the email address you have provided, quoting your unique reference number. We endeavour to review all requests as soon as possible, but no later than within 48 hours of receipt, during our normal business hours (see Business hours and holidays ( https://www.ema.europa.eu/en/about-us/c… )). Should you need to contact us in relation to this request please submit your updated query through the webform ( https://www.ema.europa.eu/en/about-us/c… ), quoting the ASK reference number given above. Kind regards,
Europäische Arzneimittel-Agentur
Access to documents requests ASK-77120 and ASK-77118 concerning Moderna and Comirnaty Dear Mr Antragsteller/in, I…
Von
Europäische Arzneimittel-Agentur
Betreff
Access to documents requests ASK-77120 and ASK-77118 concerning Moderna and Comirnaty
Datum
8. Januar 2021 11:13
Status
Anfrage abgeschlossen
436,0 KB
Dear Mr Antragsteller/in, I am writing in regard to your recent correspondence concerning Moderna and Comirnaty vaccines. You have contacted the European Medicines Agency's Press office in order to request access to documents. Colleagues have passed your requests to the Documents Access and Publication Service were we have logged them in the AskEMA system. Request concerning Moderna has a reference number ASK-77120 and the request concerning Comirnaty has a reference number ASK-77118. You should have received 2 automated acknowledgements. As they are now your requests are not clear and in order to start an access to documents procedure we would like to ask for further clarification. Towards requests for information received via the EMA web form, EMA has an obligation to reply in the language the request has been submitted, as long as it is one of the EU official languages. However, your requests are requests for access to documents. Most documents EMA holds are in the official EMA working language, which is English. Documents related to the marketing authorisation applications for Moderna and Comirnaty vaccines are in English. Also the decision letters concerning the ATD procedure are drafted in the official working language, therefore, we are hoping that, in order to speed up the process, the clarification can be carried out in English too. As for the request ASK-77118 concerning Comirnaty, you have asked to receive the marketing authorization application and the assessment report for the vaccine. The assessment report is available on the EMA web site. Please find a link for your convenience: https://www.ema.europa.eu/en/documents/… Please note that a marketing authorisation application dossier consists of hundreds of documents. Prior release, EMA has to examine each document individually to ensure that no private or public interests are being compromised. The release of a full dossier over an access to documents procedure might take years. Therefore, we would like to ask you to consider which of the documents from the dossier you would like to receive, it might be possible that you are interested only in few of the documents depending on their scope. I am attaching a structure of a MAA for your reference. Could you please confirm which documents of the dossier you would like to request. As for the request ASK-77120, you have asked to receive the marketing authorization application and the assessment report. The latter will be made available on the EMA web site shortly. Likely towards the end of the next week. As for the MAA for Moderna vaccine the same applies as above. Please kindly provide a list of the documents from the dossier that you would like to receive. Do not hesitate to contact me if you need more information. I will be awaiting your feedback in order to start the access to documents procedure. Thank you, Kind regards,
<< Anfragesteller/in >>
AW: Access to documents requests ASK-77120 and ASK-77118 concerning Moderna and Comirnaty [#208044]
Dear Ms Elfa, …
An Europäische Arzneimittel-Agentur Details
Von
<< Anfragesteller/in >>
Betreff
AW: Access to documents requests ASK-77120 and ASK-77118 concerning Moderna and Comirnaty [#208044]
Datum
8. Januar 2021 12:16
An
Europäische Arzneimittel-Agentur
Status
E-Mail wurde erfolgreich versendet.
Dear Ms Elfa, Thank you very much for your fast reponse. For the moment I'm happy with the assessment report and will therefore close my inquiry. ... Kind regards, Antragsteller/in Antragsteller/in Anfragenr: 208044 Antwort an: <<E-Mail-Adresse>> Laden Sie große Dateien zu dieser Anfrage hier hoch: https://fragdenstaat.de/a/208044/ Postanschrift Antragsteller/in Antragsteller/in << Adresse entfernt >>

Unterstützen Sie unsere Arbeit!

Mit Ihrer Spende halten Sie die Plattform am Laufen, ermöglichen neue Features sowie Support vom FragDenStaat-Team. Kämpfen Sie mit uns für mehr Transparenz in Politik und Verwaltung!

Jetzt spenden

Europäische Arzneimittel-Agentur
RE: Access to documents requests ASK-77120 and ASK-77118 concerning Moderna and Comirnaty [#208044]
Thank you Mr A…
Von
Europäische Arzneimittel-Agentur
Betreff
RE: Access to documents requests ASK-77120 and ASK-77118 concerning Moderna and Comirnaty [#208044]
Datum
12. Januar 2021 15:24
Status
Warte auf Antwort
Thank you Mr Antragsteller/in. Both of your requests have been closed. You are always welcome to submit a new request via the webform if you require documents at a later stage. Kind regards, Elfa Classified as confidential by the European Medicines Agency